Navigation Links
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
Date:11/27/2008

LUGANO, Switzerland, November 27 /PRNewswire/ -- Helsinn Healthcare's Top management today announced that it has signed a partnering agreement with Zealand Pharma, for the development and worldwide commercialization of ZP1846, a GLP-2 (glucagon-like peptide-2) receptor agonist which provides a novel way to treat chemotherapy-induced diarrhea (CID), a debilitating condition affecting patients undergoing cancer treatment with a range of chemotherapies.

Under the terms of the agreement, Helsinn Healthcare will receive a worldwide exclusive license to ZP1846 and will be responsible for all further development, regulatory approvals, manufacturing, marketing and sales of the compound either on its own or through its sub-licensees. In return Helsinn Healthcare will pay Zealand Pharma development milestones and sales milestones for an undisclosed amount. In addition, Zealand Pharma will receive royalties on future sales and Zealand Pharma retains the marketing rights to the Nordic countries. The total value of the non royalty portion of the partnership is valued at EUR 140 million.

Zealand Pharma has applied its knowledge of peptide optimization and its proprietary SIP(r) technology to develop ZP1846, one of a series of novel peptides that specifically enhance the growth and function of the lining of the intestine. ZP1846 has completed Phase I in humans in the US. Zealand Pharma's pre-clinical studies have demonstrated that ZP1846 is useful in the prevention and/or treatment of injuries to the intestinal epithelium caused by chemotherapy treatment, resulting in a reduction in the incidence of chemotherapy-induced diarrhea. Today, serious gastrointestinal side effects are observed in up to 50% of patients undergoing certain forms of chemotherapy, which in turn may require dose modification or cessation of cancer chemotherapy.

"We are excited about this promising development and commercial cooperation w
'/>"/>

SOURCE Helsinn Healthcare SA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
5. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
6. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
10. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosyste...s re-filed the Form 52-109F1 Certification of Annu...Officer and James Long, the Chief Financial Office... 2009 in connection with the annual audited financ...08. ,, The Company initially filed the annual f...
(Date:11/6/2009)...Mass., Nov. 6 Myriant Technologies...per and manufacturer of renewable bio-chemicals, ...nology provider Uhde GmbH, one of the world,s lead...unced an alliance for the engineering, procurement...ccinic Acid plants based on renewable feedstocks. ...
(Date:11/6/2009)...ALLEY, Calif., Nov. 6 Calbiotech, ...all Business Innovative Research (SBIR) Phase I co...ial command. Under terms of the agreement, Calbiot...for the diagnosis of Dengue virus. ,, Dengue...ts a major threat to military forces deployed to t...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 ...ch is set to take place on February 22-24, 2010 in...ay conference we will highlight key issues in form...hare their experiences. , ...genda for Arrowhead’s 2010 Personalized Med...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...gh net flow rate supports a multitude of hi...ions, PITTSBURGH, June 19 CardiacAssist, Inc., a...elops, manufacturers and markets,cardiac assist de...worldwide procedure utilizing the TandemHeart Syst... acceptance and use by cardiologists and surgeons....
... Cardica, Inc.,(Nasdaq: CRDC ) today announced th...resident and chief executive officer, is scheduled... Conference on Thursday, June 26, 2008,at 12:30 p....e Mandarin,Oriental, New York., To access the liv...ation, go to the Investor Relations section of the...
...ca, June 19 Neuftec,Limited, the proprietor of th...lyst technology, which recently issued a claim aga...iary of Oxonica PLC, for infringement of its,Europ...nted on a,fundamental inaccuracy in Oxonica,s AGM ...008., Dr Kevin Matthews stated in the recent Regu...
Other Biology Technology:CardiacAssist, Inc. Surpasses 1300 TandemHeart System Procedures 2Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLC's Regulatory Announcement 2
(Date:11/6/2009)...harmony with their arboreal hosts. But new researc...r trees of choice, the ants can get destructive to... the November issue of the American Naturalist , ...trees, and it reopens a centuries-old debate on th...nd certain species of plants and trees have cozy r...
(Date:11/5/2009)...eachers (NABT) will recognize Leonard C. Yannielli...lley Community College (NVCC) in Waterbury, Connec...ing the NABT annual professional development confe...lorado. , The Evolution Education Award is cospo...ences,(AIBS) and Biological Sciences Curriculum S...
(Date:11/4/2009)... reluctant to officially endorse green tea as a ca... about its protective effects, including results o...arch , a journal of the American Association for C...ral cancer. , Vassiliki Papadimitrakopoulo, M.D...acic/Head and Neck Medical Oncology at the Univers...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Insulet Establishes Eco Friendly Disposal Program for the OmniPod 28R 29 Insulin Management System 51036 1Insulet Establishes Eco Friendly Disposal Program for the OmniPod 28R 29 Insulin Management System 51036 2A Unique Rhythm In The Heart Of Coconut Grove Florida 51034 1A Unique Rhythm In The Heart Of Coconut Grove Florida 51034 2Stereotaxis Announces Second Quarter 2009 Earnings Release Date and Conference Call 51032 1Stereotaxis Announces Second Quarter 2009 Earnings Release Date and Conference Call 51032 2
...red light green light," winners are able to stop, ...r comrades. New research reveals that a similar ra...ng the big winner. , "The research provides new in...h helps explain the impulsivity of people with att...co-author Jeffrey Schall, E. Bronson Professor of ...
...onal light on how erectile dysfunction (ED) intera...covering the link between the two disorders, and m... study, "Lack of Central Nitric Oxide Triggers Ere...ong Zheng, William G. Mayhan, and Kaushik P. Patel...gy; and Keshore R. Bidasee, Department of Pharmaco...
... paleoethnobotanist at the University of Missouri-...archaeological sites ranging from the Bahamas to p...esticated chili peppers as long as 6,000 years ago...ticated food sources in the Americas. The study wi...nal Science. , "Before our research, there wasn,t ...
Other Biology News:Racing neurons control whether we stop or go 2Racing neurons control whether we stop or go 3Erectile dysfunction in diabetes is due to selective defect in the brain 2Erectile dysfunction in diabetes is due to selective defect in the brain 3Researchers find 6,000-year-old fossil evidence 2
...s are custom designed to meet your needs. Two prob...55 features per array (2 arrays/1" x 3" glass slid... Features 60-mer oligonucleotide probe length ... compared to traditional shorter length probes. It...
...e intended for laboratory research use only. The ...formalin and embedded in paraffin. Tissue identif...athologists. Tissue cores were removed from their...t paraffin block, in an array pattern, using Chemi...
...e intended for laboratory research use only. The ...formalin and embedded in paraffin. Tissue identif...athologists. Tissue cores were removed from their...t paraffin block, in an array pattern, using Chemi...
...ck image analysis software for microarray includin... for high quality and high throughput array system... robust algorithms, actual spot boundary, flexible...tion and dust removal, enhancing the accuracy of s...
Biology Products: